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Erythrocyte invasion by malaria parasites is mediated by specific molecular interactions. Sialic acid residues
of glycophorin A are used as invasion receptors by Plasmodium falciparum. In vitro invasion studies have
demonstrated that some cloned P. falciparum lines can use alternate receptors independent of sialic acid
residues of glycophorin A. It is not known if invasion by alternate pathways occurs commonly in the field. In
this study, we used in vitro growth assays and erythrocyte invasion assays to determine the invasion phenotypes
of 15 P. falciparum field isolates. Of the 15 field isolates tested, 5 multiply in both neuraminidase and
trypsin-treated erythrocytes, 3 multiply in neuraminidase-treated but not trypsin-treated erythrocytes, and 4
multiply in trypsin-treated but not neuraminidase-treated erythrocytes; 12 of the 15 field isolates tested use
alternate invasion pathways that are not dependent on sialic acid residues of glycophorin A. Alternate invasion
pathways are thus commonly used by P. falciparum field isolates. Typing based on two polymorphic markers,
MSP-1 and MSP-2, and two microsatellite markers suggests that only 1 of the 15 field isolates tested contains
multiple parasite genotypes. Individual P. falciparum lines can thus use multiple invasion pathways in the field.
These observations have important implications for malaria vaccine development efforts based on EBA-175,
the P. falciparum protein that binds sialic acid residues of glycophorin A during invasion. It may be necessary
to target parasite ligands responsible for the alternate invasion pathways in addition to EBA-175 to effectively
block erythrocyte invasion by P. falciparum.
Malaria parasites are obligate intracellular parasites that
invade erythrocytes during the blood stage of their life cycle.
The invasion of erythrocytes by malaria parasites is a multistep
process that is mediated by specific molecular interactions be-
tween erythrocyte receptors and parasite ligands (2, 29). For
example, the human malaria parasite Plasmodium vivax is ab-
solutely dependent on the Duffy blood group antigen for the
invasion of human erythrocytes (15). Duffy-negative erythro-
cytes lack the Duffy blood group antigen and are completely
resistant to invasion by P. vivax. P. falciparum, on the other
hand, does not require interaction with the Duffy blood group
antigen for invasion and invades both Duffy-positive and
Duffy-negative erythrocytes. Sialic acid residues of glycophorin
A have been identified as invasion receptors for P. falciparum
(3, 8, 16, 20). A 175-kDa P. falciparum protein, referred to as
EBA-175 (for erythrocyte binding antigen-175 kDa), specifi-
cally binds sialic acid residues of glycophorin A to mediate
erythrocyte invasion (4).
Unlike P. vivax, P. falciparum is not completely dependent
on a single receptor for the invasion of human erythrocytes.
Erythrocyte invasion studies with cloned P. falciparum lines
revealed significant heterogeneity in the receptors used for
invasion (9, 18, 21). P. falciparum clones such as HB3 and 7G8
invade neuraminidase-treated human erythrocytes, indicating
that they can use sialic acid-independent invasion pathways
(7). Other cloned parasite lines such as Dd2 and FCR3 are
completely dependent on sialic acid residues for invasion but
invade trypsin-treated erythrocytes that have lost glycophorin
A. Dd2 and FCR3 can use sialic acid residues present on both
glycophorin A as well as trypsin-resistant glycophorin B as
receptors for invasion (7).
It is not known if the use of alternate invasion pathways
observed with cloned P. falciparum lines actually occurs in the
field. If it does, how commonly do P. falciparum field isolates
use alternate invasion pathways that are independent of sialic
acid residues of glycophorin A? The answer to this question
has important implications for efforts to develop malaria vac-
cines based on EBA-175 that attempt to elicit antibodies to
block binding of EBA-175 to erythrocytes and inhibit invasion.
EBA-175 does not bind erythrocytes that lack either sialic acid
residues or glycophorin A (4, 7) and therefore cannot mediate
erythrocyte invasion by alternate pathways.
In this report, we have studied the invasion phenotypes of P.
falciparum field isolates collected from different regions of
India. In vitro parasite growth assays and erythrocyte invasion
assays with normal, neuraminidase-treated, and trypsin-treated
target erythrocytes were used to determine the invasion phe-
notypes of P. falciparum field isolates. These studies indicate
that P. falciparum field isolates commonly use alternate inva-
sion pathways that do not depend on sialic acid residues of
glycophorin A. The parasite ligands responsible for the inva-
sion of human erythrocytes by alternate pathways remain to be
identified. It may be necessary to target such ligands in addi-
tion to EBA-175 in order to effectively block erythrocyte inva-
sion by P. falciparum.
MATERIALS AND METHODS
P. falciparum field isolates. Cryopreserved P. falciparum field isolates were
obtained from the Malaria Parasite Bank maintained by the Malaria Research
Centre, Delhi, India. P. falciparum field isolates were collected from malaria
patients from different regions of India and cryopreserved in liquid nitrogen by
using standard procedures. Cloned P. falciparum lines Dd2 and 7G8 were pro-
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vided by Tom Wellems, Laboratory of Parasitic Diseases, National Institutes of
Health, Bethesda, Md. Parasites were thawed and cultured in candle jars ac-
cording to the method of Trager and Jensen (28) for two to five cycles to a
parasitemia of 2 to 5% before use in parasite growth or erythrocyte invasion
assays. Parasite cultures were maintained in A1 erythrocytes at 5% hematocrit in
RPMI 1640 medium (Gibco BRL Laboratories, Gaithersburg, Md.) supple-
mented with 10% AB1 human serum, gentamicin (10 mg/ml), 25 mM sodium
bicarbonate, and 25 mM HEPES.
Enzymatic treatment of erythrocytes. Normal A1 erythrocytes were collected
in citrate-phosphate-dextrose solution, plasma was removed, and erythrocytes
were washed three times in RPMI 1640. The cells were stored at 40 to 50%
hematocrit in RPMI 1640 at 4°C for up to 2 weeks until used. Erythrocytes were
treated with neuraminidase and trypsin as described earlier (9).
The efficiency of the neuraminidase and trypsin treatments was assayed by
agglutination assays using monoclonal antibodies M2A1 and 12E.A1, directed
against the M and N epitopes, respectively, of glycophorin A, using procedures
described by the manufacturer (Gamma Biologicals, Houston, Tex.). Loss of
agglutination confirmed complete removal of the M and N epitopes, which are
sensitive to both neuraminidase and trypsin treatment.
In vitro parasite growth assay. P. falciparum field isolates were tested for
growth in normal, neuraminidase-treated, and trypsin-treated erythrocytes, using
methods described earlier (6). Parasites were thawed and grown for two to five
cycles to an asynchronous parasitemia of 2 to 5% in normal A1 erythrocytes. An
inoculum from this culture was delivered to fresh 5-ml cultures containing either
untreated, neuraminidase-treated, or trypsin-treated human erythrocytes to an
initial parasitemia of 0.1 to 0.3%. Parasitemia was estimated at 24-h intervals for
7 days by scoring the number of infected erythrocytes per 1,000 erythrocytes on
Giemsa-stained thin smears. To correct for growth in normal erythrocytes car-
ried over during inoculation, an inoculum was also delivered in rhesus erythro-
cytes, which are known to be resistant to invasion by P. falciparum. The para-
sitemia in control, rhesus cultures can be attributed to invasion of human
erythrocytes carried over with the inoculum. The corrected parasitemia in test
erythrocytes was determined by subtracting the parasitemia in rhesus erythro-
cytes from the parasitemia in test cultures. Growth assays were set up in dupli-
cate, and the average parasitemia 6 range is reported.
In vitro erythrocyte invasion assay. Erythrocyte invasion efficiencies of P.
falciparum field isolates in normal and enzyme-treated erythrocytes were deter-
mined by methods described previously (7). Parasite cultures were synchronized
by sorbitol treatment, and late-stage schizonts were enriched by flotation on 60%
Percoll. Parasitized erythrocytes enriched to 60 to 90% parasitemia were washed
twice with RPMI 1640, counted with a hemocytometer, and mixed with target
erythrocytes in triplicate wells. Then 1 3 106 to 2 3 106 parasitized erythrocytes
were mixed with 1 3 107 to 5 3 107 target erythrocytes in 0.5 ml of complete
RPMI 1640 medium and incubated in a candle jar at 37°C for 16 to 20 h. Invasion
efficiency was determined by counting the number of parasitized erythrocytes per
1,000 erythrocytes on Giemsa-stained thin smears. Rhesus erythrocytes, which
are resistant to P. falciparum invasion, were used to correct for invasion into
normal human erythrocytes carried over during inoculation. The invasion effi-
ciency in test erythrocytes was determined by subtracting the parasitemia in
rhesus cultures from the parasitemia in test cultures. Average invasion efficien-
cies 6 standard deviation determined in two independent experiments are re-
ported.
PCR-based typing of P. falciparum field isolates. PCR amplification of gene
fragments encoding polymorphic regions of blood-stage parasite proteins, MSP-1
and MSP-2, and two microsatellite markers, TA62 and TA77, was used to type
the P. falciparum field isolates and determine if they contain multiple clones.
Genomic DNA was isolated from each P. falciparum isolate by the Chelex-
boiling method described earlier (30). PCR typing of P. falciparum field isolates
by using the two polymorphic markers MSP-1 and MSP-2 has been described
elsewhere (12, 13, 25, 26).
(i) MSP-1. Oligonucleotide primers based on conserved sequences flanking
the polymorphic block 2 region of MSP-1 were used for PCR amplification (12,
13, 26). The PCR products were separated on 6% polyacrylamide gels and
visualized by ethidium bromide staining. The PCR products were transferred to
nylon membrane and typed by hybridization with 32P-labeled oligonucleotide
probes based either on the major dimorphic forms, K1 and MAD20, which
contain distinctive repeat sequences, or the third variant, R033, which lacks
repeat sequences (12, 13, 26). Sequences of the PCR primers and oligonucleotide
probes used as well as PCR amplification and hybridization conditions were
identical to those described earlier (12, 13, 26).
(ii) MSP-2. Oligonucleotide primers based on conserved sequences flanking
the central polymorphic regions, blocks 2 and 3, of MSP-2 were used for PCR
amplification (13, 25). The PCR products were separated on 6% polyacrylamide
gels and visualized by ethidium bromide staining. The PCR products were trans-
ferred to nylon membrane and typed by hybridization using 32P-labeled oligo-
nucleotide probes specific for the FC27 and CAMP-type MSP-2 sequences. The
sequences of the PCR primers and oligonucleotide probes and the conditions for
PCR and Southern hybridization were identical to those described by Kyes et al.
(13).
(iii) TA62 and TA77. The use of microsatellite polymorphisms to type P.
falciparum strains has been described by Su and Wellems (27). Microsatellite
markers comprise a variable number of simple sequence repeats that are widely
distributed in the parasite genome. Two such microsatellite markers, TA62 and
TA77, were PCR amplified by using oligonucleotide primers and PCR conditions
described by Su and Wellems (27). One primer of each PCR primer pair was
labeled with 32P to yield radiolabeled PCR products. The PCR products were
separated on 6% polyacrylamide sequencing gels and detected by autoradiogra-
phy.
RESULTS
Growth of P. falciparum field isolates in normal, neuramin-
idase-treated, and trypsin-treated human erythrocytes. In
vitro parasite growth assays were performed with 15 P. falci-
parum field isolates. Two cloned P. falciparum lines, Dd2 and
7G8, were used as controls. Dd2 is known to invade trypsin-
treated erythrocytes but not neuraminidase-treated erythro-
cytes (7). Conversely, 7G8 invades neuraminidase-treated
erythrocytes but not trypsin-treated erythrocytes (7). The
growth curves of Dd2 and 7G8 reflect their invasion pheno-
types (Fig. 1). The growth curves of four P. falciparum field
isolates are also shown in Fig. 1. The P. falciparum field isolate
RAJ203 multiplies in normal human erythrocytes but not in
neuraminidase-treated or trypsin-treated human erythrocytes.
In contrast, the P. falciparum field isolate RAJ24 multiplies in
both neuraminidase-treated and trypsin-treated human eryth-
rocytes. The growth curve of the P. falciparum field isolate
RAJ220 is similar to that of Dd2. Both RAJ220 and Dd2
multiply in trypsin-treated erythrocytes but not in neuramini-
dase-treated erythrocytes. In contrast, the P. falciparum field
isolate RAJ68 has a growth curve similar to that of 7G8. Both
RAJ68 and 7G8 multiply in neuraminidase-treated but not in
trypsin-treated human erythrocytes.
The growth curves shown (Fig. 1) are representative of the
growth curves of the 11 other P. falciparum field isolates that
were tested. Table 1 shows the parasitemia of each P. falcipa-
rum field isolate in enzyme-treated erythrocytes as a percent-
age of the parasitemia in normal human erythrocytes on day 7
of the growth assay. If the day 7 parasitemia in enzyme-treated
erythrocytes is greater than 20% of the day 7 parasitemia in
normal erythrocytes, the parasite isolate is considered to be
positive for growth in the enzyme-treated erythrocytes. By this
criterion, only 3 of the 15 isolates tested do not multiply in
either neuraminidase-treated or trypsin-treated human eryth-
rocytes; in contrast, of the 15 isolates tested, 5 multiply in both
neuraminidase-treated and trypsin-treated erythrocytes, 3 mul-
tiply in neuraminidase-treated but not in trypsin-treated eryth-
rocytes, and 4 multiply in trypsin-treated but not in neuramin-
idase-treated erythrocytes. These data suggest that 12 of the 15
field isolates tested can use alternate invasion pathways that
are independent of sialic acid residues of glycophorin A for
invasion.
P. falciparum field isolate RKL9 uses multiple pathways to
invade erythrocytes. The field isolates used in this study were
derived from P. falciparum malaria patients. Isolates such as
RKL9, which grow in both neuraminidase-treated and trypsin-
treated erythrocytes, may contain multiple P. falciparum lines,
including one that invades neuraminidase-treated erythrocytes
and another that invades trypsin-treated erythrocytes. Alter-
nately, RKL9 may contain a clonal parasite line that invades
both neuraminidase-treated and trypsin-treated erythrocytes.
To distinguish between these possibilities, RKL9 was cultured
separately in both neuraminidase-treated and trypsin-treated
human erythrocytes for 7 days. Parasites cultured in neuramin-
idase-treated erythrocytes (RKL9Neu) were reinoculated on
day 7 in normal, neuraminidase-treated, and trypsin-treated
human erythrocytes at a parasitemia of 0.2%. Parasite growth
was monitored at 24-h intervals for another 7 days. Similarly,
parasites cultured in trypsin-treated erythrocytes (RKL9Try)
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were reinoculated on day 7 in normal, neuraminidase-treated,
and trypsin-treated human erythrocytes at a parasitemia of
0.2% and parasite growth was monitored for another 7 days.
Both RKL9Neu and RKL9Try parasites multiplied in neura-
minidase-treated as well as trypsin-treated erythrocytes (Fig.
2). PCR typing data based on two polymorphic markers,
MSP-1 and MSP-2, and two microsatellite markers also suggest
that RKL9 contains a single parasite line (described below). It
thus appears likely that RKL9 is composed of a single parasite
line that invades both neuraminidase-treated and trypsin-
treated erythrocytes.
Erythrocyte invasion assays confirm the invasion pheno-
types of P. falciparum field isolates determined by in vitro
growth assays. Five of the 15 P. falciparum field isolates that
FIG. 1. Growth of P. falciparum field isolates in normal and enzyme-treated erythrocytes. Cloned P. falciparum lines (Dd2 and 7G8) and P. falciparum field isolates
(RAJ203, RAJ24, RAJ220, and RAJ68) were inoculated in normal (closed squares), neuraminidase-treated (open squares), and trypsin-treated (asterisk) erythrocytes
and cultured for 7 days. Parasitemia at 24-h intervals is shown.
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were tested in parasite growth assays were also tested in eryth-
rocyte invasion assays with normal and enzyme-treated eryth-
rocytes. P. falciparum schizonts were purified and incubated
with normal and enzyme-treated erythrocytes to allow inva-
sion. The invasion rates were determined by scoring the per-
centage of infected erythrocytes in normal and test erythro-
cytes. The cloned P. falciparum lines, Dd2 and 7G8, were used
as controls. The invasion rates of P. falciparum field isolates
into enzyme-treated erythrocytes are shown as a percentage
of invasion rates into normal erythrocytes in Table 2. The
invasion rates of the P. falciparum field isolates confirm the
invasion phenotypes predicted by the growth assays. The P.
falciparum field isolates RKL9 and JDP8 invade both neura-
minidase-treated and trypsin-treated erythrocytes. In addition,
whereas RKL12 and RAJ68 invade neuraminidase-treated but
not trypsin-treated erythrocytes, RAJ104 invades trypsin-
treated but not neuraminidase-treated erythrocytes. None of
the isolates tested invade erythrocytes treated with both neur-
aminidase and trypsin.
Genotyping P. falciparum field isolates by using polymorphic
markers. P. falciparum field isolates used in this study were
derived from malaria patients and may contain multiple para-
site lines. PCR amplification of DNA encoding polymorphic
regions of two merozoite surface proteins, MSP-1 and MSP-2,
and two microsatellite markers, TA77 and TA62, was used to
type field isolates and determine if they contain more than one
P. falciparum genotype (12, 13, 25, 26, 27).
In the case of MSP-1, DNA encoding the polymorphic re-
peat region at the N-terminal end (block 2) was PCR amplified
by using primers based on conserved sequences in the flanking
regions. Each field isolate except RAJ133 yielded a single PCR
product with the MSP-1 primers (Fig. 3). RAJ133 yielded three
distinct PCR products with the MSP-1 primers, suggesting that
it contains multiple parasite genotypes (Fig. 3). The PCR prod-
ucts were assessed for presence of the three MSP-1 sequence
types, K1, MAD20, and R033, using type-specific, 32P-labeled
oligonucleotide probes for hybridization. Two of the three
PCR products from RAJ133 hybridized with the K1-type
probe, and the third PCR product hybridized with the MAD20-
type probe; PCR products derived from each of the other field
isolates hybridized with unique, type-specific probes (Table 3).
PCR typing based on block 2 of MSP-1 suggests that RAJ133
contains more than one P. falciparum genotype.
PCR typing based on the central polymorphic regions
(blocks 2 and 3) of MSP-2 confirmed the observations made
with MSP-1 primers. As in case of MSP-1, all isolates except
RAJ133 yielded unique PCR products with the MSP-2 primers
(Fig. 3). RAJ133 yielded two distinct PCR products with the
MSP-2 primers. One of the products hybridized with an FC27-
specific probe, and the other hybridized to a CAMP-specific
probe, confirming presence of more than one parasite geno-
type (Table 3). PCR products derived from each of the other
field isolates hybridized with either FC27 or CAMP-specific
probes, suggesting that each contains a single parasite geno-
type (Table 3).
In addition to the polymorphic antigens, two microsatellite
markers, TA62 and TA77, were used to type the P. falciparum
field isolates. PCR amplification of the microsatellite marker
TA62 yielded a single PCR product with genomic DNA from
each isolate (Fig. 4). PCR amplification of the microsatellite
marker TA77 did not yield any product with genomic DNA
from RKL12 and RAJ220, two products with RAJ133 genomic
DNA, and a unique product with each of the other P. falcipa-
rum field isolates. Data from microsatellite markers confirm
the presence of multiple parasite genotypes in RAJ133 and
suggest that each of the other field isolates contains a single P.
falciparum genotype.
DISCUSSION
Using both in vitro growth and invasion assays, we have
characterized the invasion phenotypes of P. falciparum field
isolates. Fifteen field isolates derived from P. falciparum ma-
laria patients were tested for growth in normal, neuraminidase-
treated, and trypsin-treated erythrocytes. The field isolates dis-
played significant diversity in growth phenotypes. Whereas five
field isolates multiplied in both neuraminidase-treated and
trypsin-treated erythrocytes, four multiplied in neuraminidase-
treated but not in trypsin-treated erythrocytes and three mul-
tiplied in trypsin-treated but not in neuraminidase-treated
erythrocytes. In all, 12 of 15 field isolates tested could grow in
erythrocytes lacking either sialic acid residues or glycophorin
A. Growth in neuraminidase-treated or trypsin-treated eryth-
rocytes suggests that these isolates can invade erythrocytes
using alternate invasion pathways that are independent of
sialic acid residues of glycophorin A.
Growth assays do not directly measure erythrocyte invasion
efficiency. Lack of growth in enzyme-treated erythrocytes could
in principle result from the failure of ring stages to mature into
trophozoites or schizonts and need not necessarily result from
poor invasion efficiency. An erythrocyte invasion assay in which
the percentage of ring-infected erythrocytes is scored following
incubation of schizonts with normal and enzyme-treated eryth-
rocytes for 16 to 20 h was used to directly measure invasion
efficiencies of 5 field isolates. P. falciparum field isolates, JDP8
and RKL9, which grow in neuraminidase-treated and trypsin-
TABLE 1. Growth of P. falciparum field isolates in normal and
enzyme-treated human erythrocytesa
Parasite isolate
Day 7 parasitemia
(%; avg 6 range)
in normal)
erythrocytes
Day 7 parasitemia (% of normal;
avg 6 range) in erythrocytes treated
with:
Neuraminidase Trypsin
Dd2 23.8 6 1.8b 1.4 6 0.7 (2) 43.0 6 1.4 (1)
7G8 18.0 6 1.4 74.0 6 1.9 (1) 3.8 6 0.5 (2)
JDP8 12.2 6 1.1 24.5 6 1.0 (1) 42.0 6 2.9 (1)
RKL9 12.9 6 0.4 59.8 6 2.9 (1) 47.7 6 1.5 (1)
RKL12 13.1 6 0.5 33.5 6 4.3 (1) 13.0 6 0.2 (2)
RAJ24 14.8 6 0.5 56.1 6 4.6 (1) 61.9 6 1.7 (1)
RAJ68 6.6 6 1.0 42.6 6 3.2 (1) 13.9 6 3.8 (2)
RAJ86 9.4 6 1.7 22.4 6 3.3 (1) 17.7 6 2.0 (2)
RAJ87 14.1 6 1.7 4.7 6 1.0 (2) 34.1 6 2.6 (1)
RAJ89 12.7 6 0.5 43.9 6 2.3 (1) 24.2 6 2.3 (1)
RAJ104 14.6 6 1.0 1.8 6 0.7 (2) 34.4 6 3.1 (1)
RAJ116 10.6 6 2.1 10.7 6 0.4 (2) 8.6 6 1.9 (2)
RAJ133 17.7 6 0.8 73.7 6 2.5 (1) 28.8 6 4.1 (1)
RAJ203 16.1 6 2.4 7.1 6 0.6 (2) 7.7 6 1.7 (2)
RAJ220 15.0 6 1.3 9.4 6 1.8 (2) 63.4 6 1.5 (1)
SH8777 11.1 6 2.0 10.1 6 2.7 (2) 9.2 6 2.1 (2)
DL4 18.0 6 1.8 5.5 6 0.3 (2) 38.2 6 1.4 (1)
a Fifteen P. falciparum field isolates and two cloned P. falciparum lines (Dd2
and 7G8) were inoculated into normal and enzyme-treated human erythrocytes
as well as normal rhesus erythrocytes at a parasitemia of 0.1 to 0.3% in duplicate
wells and cultured for 1 week. Growth in normal erythrocytes carried over with
the inoculum was corrected for by subtracting the parasitemia in rhesus eryth-
rocytes from the parasitemia in test erythrocytes. Day 7 parasitemia in rhesus
erythrocytes was less than 5% of the day 7 parasitemia in normal erythrocytes in
all cases. If the day 7 parasitemia in enzyme-treated erythrocytes is greater than
20% of the day 7 parasitemia in normal erythrocytes, the parasite isolate is
considered positive for growth in the enzyme-treated erythrocytes. (1), the
parasite can multiply in the enzyme-treated erythrocytes; (2), the parasite can-
not multiply in the enzyme-treated erythrocytes.
b Parasitemia on day 4.
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treated erythrocytes, could invade these erythrocytes. In addi-
tion, RKL12 and RAJ68 could invade neuraminidase-treated
erythrocytes and RAJ104 could invade trypsin-treated eryth-
rocytes, as predicted by data from the growth assays. Correla-
tion of invasion efficiency and growth rates suggests that data
from growth assays can be used to correctly predict invasion
phenotypes. The use of alternate invasion pathways that are
independent of binding to sialic acid residues of glycophorin A
was initially observed with cloned P. falciparum lines (7, 18,
21). Data presented here demonstrate that the use of alternate
invasion pathways is not simply an artifact of long-term in vitro
culture but commonly occurs in the field.
The field isolates used in this study were derived from P.
falciparum malaria patients. PCR amplification of DNA en-
coding polymorphic regions of two merozoite surface proteins,
MSP-1 and MSP-2, and two microsatellite markers was used to
determine if the field isolates contain multiple parasite lines.
PCR typing data based on these four markers suggest that only
1 of 15 P. falciparum field isolates, RAJ133, contains multiple
parasite lines. Three of the four polymorphic markers used for
typing could detect the presence of multiple parasite genotypes
in RAJ133. It is unlikely that the typing methods used would
fail to detect the presence of multiple genotypes in other field
isolates. However, it is not possible to completely rule out the
presence of more than one genotype based on these four poly-
morphic markers.
The field isolates were cultured for two to five cycles before
use in the growth assays and isolation of genomic DNA for
analysis by PCR typing. Differences in growth rates could re-
sult in the survival of a single parasite line when a field isolate
containing multiple parasite lines is cultured in vitro. Alter-
nately, the absence of multiple parasite lines may be due to the
fact that majority of the field isolates (12 of 15) used in this
study were collected from regions of sporadic, unstable malaria
transmission (e.g., Rajasthan, Delhi, and Uttar Pradesh),
which are likely to have low entomological inoculation rates
and limited number of variants in the parasite population.
Given that the field isolates were collected in areas of low
endemicity, it is possible that one or two parasite isolates were
circulating and were the predominant ones sampled. Such an
error in sampling could lead to an overestimation of the pro-
portion of field isolates using alternate pathways. The results
from PCR typing demonstrate that the field isolates sampled
FIG. 2. Multiple erythrocyte invasion pathways used by P. falciparum field isolate RKL9. P. falciparum field isolate RKL9 was cultured in normal, neuraminidase-
treated, and trypsin-treated erythrocytes for 7 days. Parasites growing in either neuraminidase-treated erythrocytes (RKL9Neu) or trypsin-treated erythrocytes
(RKL9Try) were reinoculated in normal, neuraminidase-treated, and trypsin-treated erythrocytes on day 7 and cultured for another 7 days. Parasitemia of RKL9,
RKL9Neu, and RKL9Try in normal (closed squares), neuraminidase-treated (open squares), and trypsin-treated (crosses) erythrocytes at 24-h intervals is shown.
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were unique and independent, allowing us to exclude this pos-
sibility.
Unlike P. falciparum, P. vivax is completely dependent on
the Duffy antigen for invasion of human erythrocytes (15). The
related simian malaria parasite, P. knowlesi, is also completely
dependent on the Duffy antigen for invasion of human eryth-
rocytes but can use multiple Duffy antigen independent path-
ways to invade rhesus erythrocytes (10, 14). Redundancy in
erythrocyte invasion pathways may provide a survival advan-
tage to P. falciparum and P. knowlesi in case of receptor het-
erogeneity in host populations or immune pressure (17). P.
falciparum EBA-175, which binds sialic acid residues of glyco-
phorin A, belongs to a family of erythrocyte binding proteins
which also includes the P. vivax and P. knowlesi Duffy binding
proteins and the P. knowlesi b and g proteins, which are re-
sponsible for invasion of rhesus erythrocytes by Duffy antigen-
independent pathways (1, 5). The functional binding domain
lies in a conserved, N-terminal, cysteine-rich region, referred
to as region II, that is present in each member of the erythro-
cyte binding protein family (5, 24). Amino acid sequence vari-
ation within region II confers diverse binding specificity to
different members of the erythrocyte binding protein family. P.
falciparum proteins that mediate invasion by alternate path-
ways have not yet been identified. EBA-175 homologues with
variant binding domains (region II) may bind alternate recep-
tors to mediate invasion by pathways that are independent of
sialic acid residues of glycophorin A. Genes encoding EBA-175
homologues have been identified in P. falciparum, but their
roles in erythrocyte binding and invasion remain to be deter-
mined (22).
Expression of multiple members of the erythrocyte binding
protein family allows P. knowlesi to invade rhesus erythrocytes
by multiple pathways (1, 5, 10). Analysis of gene expression at
the single merozoite level has demonstrated that P. yoelii
merozoites derived from a single schizont may express differ-
ent members of a family of rhoptry proteins that bind eryth-
rocytes to mediate invasion (11, 19, 23). Different members of
the rhoptry protein family may have distinct binding specificity.
Each cohort of P. yoelii merozoites released upon schizont
rupture can thus invade erythrocytes by multiple pathways by
using diverse receptors. As in the case of P. yoelii, P. falciparum
merozoites released from a single schizont may express differ-
ent members of the erythrocyte binding protein family with
diverse receptor binding specificity, allowing a cohort of P.
falciparum merozoites to invade by multiple pathways. Such a
mechanism for differential expression of genes may provide
great diversity and plasticity in erythrocyte invasion pheno-
types to a clonal parasite population.
Efforts to develop a malaria vaccine based on EBA-175
TABLE 2. Invasion rates of P. falciparum field isolates in normal and enzyme-treated erythrocytesa
Parasite isolate
Invasion rate (avg %
parasitemia 6 SD)
in normal erythrocytes
Invasion rate (% of normal; avg 6 SD)
Neu Try Neu 1 Try Try 1 Neu
Dd2 7.6 6 0.7 21.1 6 0.1 48.7 6 0.2 27.1 6 0.2 21.3 6 0.4
8.0 6 0.5 1.6 6 0.2 52.3 6 0.3 26.3 6 0.2 21.5 6 0.3
7G8 6.3 6 0.8 69.6 6 0.4 6.3 6 0.1 22.7 6 0.1 20.9 6 0.1
5.9 6 0.5 65.4 6 0.3 3.0 6 0.1 21.9 6 0.2 1.0 6 0.1
JDP8 3.8 6 0.5 20.4 6 0.2 34.4 6 0.1 24.5 6 0.2 25.8 6 0.1
3.6 6 0.5 21.0 6 0.1 39.2 6 0.1 21.4 6 0.1 23.8 6 0.2
RKL9 4.7 6 0.8 49.6 6 0.7 37.2 6 0.2 2.1 6 0.4 1.3 6 0.4
4.1 6 0.1 55.2 6 0.3 44.3 6 0.5 6.4 6 0.2 2.0 6 0.1
RKL12 4.1 6 0.5 33.0 6 0.1 11.5 6 0.1 3.7 6 0.1 21.5 6 0.1
4.2 6 0.2 29.3 6 0.2 8.0 6 0.1 0.5 6 0.1 23.3 6 0.1
RAJ68 3.3 6 0.1 33.6 6 0.2 2.7 6 0.3 23.0 6 0.1 21.0 6 0.2
3.7 6 0.1 38.5 6 0.1 4.0 6 0.1 28.0 6 0.1 23.1 6 0.2
RAJ104 5.0 6 0.3 1.0 6 0.1 25.4 6 0.1 21.2 6 0.1 2.4 6 0.1
4.1 6 0.4 0.5 6 0.1 29.1 6 0.1 0.7 6 0.1 3.2 6 0.1
a Invasion rates of five P. falciparum field isolates (RKL9, RKL12, JDP8, RAJ68, and RAJ104) and two cloned parasite lines (Dd2 and 7G8) in normal and
enzyme-treated human erythrocytes determined in two independent experiments are shown. Purified P. falciparum schizonts were incubated in triplicate wells with
normal and enzyme-treated human erythrocytes as well as rhesus erythrocytes. Invasion into normal human erythrocytes carried over with the inoculum was accounted
for by subtracting the parasitemia in rhesus erythrocytes from parasitemia in test erythrocytes. Invasion rates in rhesus erythrocytes were less than 25% of invasion rates
in normal human erythrocytes in all cases. Enzymes (Neu, neuraminidase; Try, trypsin) are listed in the order they were applied to the erythrocytes.
FIG. 3. PCR typing of P. falciparum field isolates based on MSP-1 and
MSP-2. DNA fragments encoding the polymorphic N-terminal region (block 2)
of MSP-1 and the central, polymorphic regions (blocks 2 and 3) of MSP-2 were
amplified by PCR using genomic DNA from 15 P. falciparum field isolates
(JDP8, RKL9, RKL12, RAJ24, RAJ68, RAJ86, RAJ87, RAJ89, RAJ104,
RAJ116, RAJ133, RAJ203, RAJ220, SH8777, and DL4) and two cloned P.
falciparum lines (Dd2 and 7G8) as templates. The PCR products were separated
by electrophoresis on polyacrylamide gels and visualized by staining with
ethidium bromide. MW, molecular weights standards (sizes are shown in base
pairs).
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attempt to elicit antibodies that will block the binding of EBA-
175 to erythrocytes and inhibit erythrocyte invasion. This study
has demonstrated that P. falciparum field isolates commonly
use alternate invasion pathways that do not depend on sialic
acid residues of glycophorin A. EBA-175 does not bind eryth-
rocytes that lack either sialic acid residues or glycophorin A (4,
7) and therefore cannot be responsible for invasion by alter-
nate pathways. Antibodies directed against EBA-175 should be
tested for inhibition of erythrocyte invasion by P. falciparum
isolates that use multiple invasion pathways. Efforts to identify
the parasite ligands that mediate the alternate invasion path-
ways of P. falciparum are under way. It may be necessary to
target these parasite ligands, in addition to EBA-175, to effec-
tively block erythrocyte invasion by P. falciparum.
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